Table 2.
Demographic table for Mayo Clinic samples
| LBD − ADpath (n = 196) |
LBD + ADpath (n = 198) |
|
|---|---|---|
| Sex, n (%) | ||
| Female | 55 (28.1) | 67 (33.8) |
| Male | 141 (71.9) | 131 (66.2) |
| Age at onset, mean (SD) | 65.9 (10.8) | 70.4 (8.3) |
| Age at death, mean (SD) | 76.0 (8.6) | 78.3 (6.6) |
| Disease duration, mean (SD) | 10.0 (7.4) | 7.9 (5.5) |
| LBD type/Kosaka, n (%) | ||
| BLBD | 54 (27.6) | 6 (3.0) |
| TLBD | 84 (42.9) | 34 (17.2) |
| DLBD | 58 (29.6) | 158 (79.8) |
| Thal phase, median (Q1, Q3) | 1 (0, 2) | 4 (3, 5) |
| Braak NFT stage, median (Q1, Q3) | II (II, III) | IV (III, V) |
ADpath = Alzheimer's disease co-pathology; BLBD = brainstem Lewy body disease; DLBD = diffuse Lewy body disease; NFT = neurofibrillary tangle; Q1 = 1st quartile; Q3 = 3rd quartile; SD = standard deviation; TLBD = transitional Lewy body disease.